Handelsavisen
prelaunch
Companies Healthcare ADVE.KL
AD
ADVE.KL Bursa Malaysia Medical Equipment, Supplies & Distribution

Adventa Bhd

$0,13
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
3,7 %
ROE
0,3 %
Net margin
2,3 %
Debt / equity
0,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Adventa Bhd provides medical equipment, supplies, and distribution services within the healthcare sector, generating revenue primarily through the sale and distribution of medical products.

Business. Adventa Bhd (ADVE.KL) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related consumables. Headquartered in Malaysia, the company is listed on the Bursa Malaysia stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
0,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ADVE.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ADVE.KL. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Adventa Bhd (ADVE.KL) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related consumables. Headquartered in Malaysia, the company is listed on the Bursa Malaysia stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Adventa Bhd maintains a strong liquidity position, with a current ratio of 5.6, indicating that it holds significantly more current assets than current liabilities. However, the company reported negative operating cash flow of MYR -6,198,000 and free cash flow of MYR -4,676,000, suggesting that it is currently spending more cash than it is generating from operations. The company's capital expenditure of MYR -5,300,000 reflects ongoing investment in long-term assets, but this is being funded by negative cash flows, which could raise concerns about long-term sustainability.

    Profitability metrics for Adventa Bhd are modest, with a return on equity (ROE) of 0.33% and a return on assets (ROA) of 0.30%. These figures are below the typical thresholds for strong performance in the medical equipment and supplies industry, where higher returns are often expected due to the capital-intensive nature of the business. The company's operating income of MYR 498,000 and net income of MYR 304,000 suggest limited profitability, which may constrain its ability to reinvest in growth or reward shareholders.

    The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. This lack of diversification could expose Adventa Bhd to higher operational risk if demand for medical equipment and supplies fluctuates. Geographically, the company operates primarily in Malaysia, as indicated by the MYR-based financials, and there is no evidence of significant international exposure.

    Looking ahead, Adventa Bhd's growth trajectory appears uncertain. The company's revenue of MYR 13,503,000 is relatively flat compared to historical data, and there is no indication of a clear upward trend. The negative operating and free cash flows suggest that the company may need to rely on external financing or asset sales to fund its operations and capital expenditures, which could impact its long-term growth potential.

    The risk assessment for Adventa Bhd highlights a medium liquidity risk, primarily due to the company's negative net cash position after accounting for total debt. While the company's debt-to-equity ratio is low at 0.01, indicating minimal leverage, the negative cash flows and capital expenditures raise concerns about its ability to maintain liquidity without external financing. The risk of dilution is currently low, as there is no evidence of recent share issuance or plans for future dilution.

    No recent filings or transcripts are available in the provided data to indicate any material events or strategic shifts at Adventa Bhd. The company's financial performance and risk profile remain largely unchanged from the latest available data.

    Key takeaways
    • Adventa Bhd has a strong current ratio of 5.6, but negative operating and free cash flows raise concerns about liquidity sustainability.
    • The company's ROE and ROA are below typical industry benchmarks, indicating limited profitability.
    • Revenue is concentrated in a single business segment and geographic market, increasing operational risk.
    • Growth appears to be constrained by flat revenue and negative cash flows, with no clear upward trajectory.
    • Liquidity risk is moderate, and dilution risk is currently low.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 2

    Adventa carries minimal leverage with a debt-to-equity ratio of 0.01, well below the 0.20 median.

    The firm faces low dilution risk and low credit risk according to current risk assessments.

    BEAR CASE · 2

    Return on equity of 0.33% lags significantly behind the 1.42% cohort median.

    Cash conversion of -20.39% places the company in the bottom quartile of its peer group.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2018-12-26
    Q3 2018 · Quarter highlights

    Revenue MYR 14.0M, −17,6% YoY; Operating income −428,6% YoY.

    RevenueMYR 14.0M−17,6 % YoY
    Operating income-MYR 4.6M−428,6 % YoY
    Net income-MYR 6.4M−824,6 % YoY
    Free cash flow-MYR 6.2M−722,4 % YoY
    EPS
    Operating cash flowMYR 49.0k+100,6 % YoY
    Financials
    Income statement
    RevenueMYR 14.0M
    Gross profit
    Operating income-MYR 4.6M
    Net income-MYR 6.4M
    Margins
    Gross margin
    Operating margin-32.5%
    Net margin-45.5%
    FCF margin-44.0%
    Balance sheet
    Total assetsMYR 108.0M
    Total liabilitiesMYR 20.6M
    Total equityMYR 87.4M
    Cash & equivalents
    Long-term debtMYR 17.2M
    Cash flow
    Operating cash flowMYR 49.0k
    CapEx
    Free cash flow-MYR 6.2M
    SBC
    P&L flow · revenue → net income
    Revenue MYR 14.0MOperating costs MYR 18.6MTax MYR 1.8MNet income MYR 6.4M
    Highlights
    • Revenue MYR 14.0M, −17,6% YoY
    • Operating income −428,6% YoY
    • Net income −824,6% YoY
    • Free cash flow −722,4% YoY
    • Net margin -45.5%

    Valuation TTM

    Market price
    $0,13
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $92.5M
    Net cash
    -$789.0k
    Current ratio
    5.6
    Debt / equity
    0.0
    ROA
    0.3%
    ROE
    0.3%
    Cash conversion
    -2039.0%
    CapEx / revenue
    -39.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin3,7 %Below median
    Net Margin2,2 %Below median
    ROE0,3 %Below median
    Capex / Rev-39,2 %Bottom quartile
    D/E0,01Above P75
    Cash Conv-20,39Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Adventa Bhd Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ADVE.KLCanonical
    Bursa Malaysia · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2018-12-26 15:27 UTCEARNINGSQuarterly results — Q3 2018 Revenue MYR 14.0M · Net MYR -6.4M
    2018-09-28 19:54 UTCEARNINGSQuarterly results — Q2 2018 Revenue MYR 11.8M · Net MYR 0.2M
    2018-06-20 13:30 UTCEARNINGSQuarterly results — Q1 2018 Revenue MYR 13.9M · Net MYR 0.4M
    2018-03-28 14:46 UTCEARNINGSQuarterly results — Q4 2017 Revenue MYR 13.6M · Net MYR 0.3M
    2017-12-29 14:30 UTCEARNINGSQuarterly results — Q3 2017 Revenue MYR 17.0M · Net MYR 0.9M
    2017-12-29 14:30 UTCEARNINGSAnnual results — FY 2017 Revenue MYR 58.3M · Net MYR 2.2M
    2017-09-20 04:29 UTCEARNINGSQuarterly results — Q2 2017 Revenue MYR 15.4M · Net MYR 0.7M
    2016-12-28 04:08 UTCEARNINGSAnnual results — FY 2016 Revenue MYR 37.3M · Net MYR -9.1M
    2015-12-18 17:59 UTCEARNINGSAnnual results — FY 2015 Revenue MYR 59.0M · Net MYR -5.1M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage